<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">734127</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2021.734127</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>(-)-T-Cadinol&#x2014;a Sesquiterpene Isolated From <italic>Casearia sylvestris</italic> (Salicaceae)&#x2014;Displayed <italic>In Vitro</italic> Activity and Causes Hyperpolarization of the Membrane Potential of <italic>Trypanosoma cruzi</italic>
</article-title>
<alt-title alt-title-type="left-running-head">dos Santos et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Anti-Trypanosoma Cruzi Activity of (-)-T-Cadinol</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>dos Santos</surname>
<given-names>Augusto L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Amaral</surname>
<given-names>Maiara</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1532915/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hasegawa</surname>
<given-names>Flavia Rie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lago</surname>
<given-names>Jo&#xe3;o Henrique G.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/704609/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Tempone</surname>
<given-names>Andre G.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="fn" rid="fn2">
<sup>&#x2021;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/815281/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Sartorelli</surname>
<given-names>Patricia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="fn" rid="fn2">
<sup>&#x2021;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/572077/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Instituto de Ci&#xea;ncias Ambientais, Qu&#xed;micas e Farmac&#xea;uticas, Universidade Federal de S&#xe3;o Paulo</institution>, <addr-line>Diadema</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Centro de Parasitologia e Micologia, Instituto Adolfo Lutz</institution>, <addr-line>Santo Andr&#xe9;</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Faculdade de Medicina, Universidade de S&#xe3;o Paulo</institution>, <addr-line>S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Centro de Ci&#xea;ncias Naturais e Humanas, Universidade Federal do ABC</institution>, <addr-line>Santo Andr&#xe9;</addr-line>, <country>Brazil</country>
</aff>
<author-notes>
<corresp id="c001">&#x2a;Correspondence: Patricia Sartorelli, <email>psartorelli@unifesp.br</email>; Andre G. Tempone, <email>andre.tempone@ial.sp.gov.br</email>
</corresp>
<fn fn-type="other" id="fn2">
<label>
<bold>
<sup>&#x2021;</sup>
</bold>
</label>
<p>
<bold>ORCID:</bold>
</p>
<p>Andre G. Tempone</p>
<p>
<ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0003-2559-7344">orcid.org/0000-0003-2559-7344</ext-link>
</p>
<p>Patricia Sartorelli</p>
<p>
<ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0002-1624-8145">orcid.org/0000-0002-1624-8145</ext-link>
</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this&#x20;work</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/485944/overview">Matthias F. Melzig</ext-link>, Freie Universit&#xe4;t Berlin, Germany</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/670592/overview">Bertha Espinoza</ext-link>, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Mexico</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1451878/overview">Marta Mendel</ext-link>, Warsaw University of Life Sciences, Poland</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>11</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>734127</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>06</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>09</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 dos Santos, Amaral, Hasegawa, Lago, Tempone and Sartorelli.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>dos Santos, Amaral, Hasegawa, Lago, Tempone and Sartorelli</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Chagas disease is caused by the protozoan parasite <italic>Trypanosoma cruzi</italic> and affects 6&#x2013;8 million people worldwide, mainly from developing countries. The treatment is limited to two approved nitro-derivatives, nifurtimox and benznidazole, with several side effects and reduced efficacy. <italic>Casearia sylvestris</italic> has been used in folk medicine as an antiseptic and cicatrizing in skin diseases. In the present work, the hexane phase from the MeOH extract from the leaves of <italic>Casearia sylvestris</italic> afforded a fraction composed by the sesquiterpene T-cadinol, which was chemically characterized by NMR and HRMS. The activity of T-cadinol was evaluated against <italic>T. cruzi</italic>, and IC<sub>50</sub> values of 18 (trypomastigotes) and 15 (amastigotes)&#x20;&#xb5;M were established. The relation between the mammalian toxicity and the antiparasitic activity resulted in a selectivity index &#x3e;12. Based on this promising activity, the mechanism of action was investigated by different approaches using fluorescent-based techniques such as plasma membrane permeability, plasma membrane electric potential, mitochondrial membrane electric potential, reactive oxygen species, and the intracellular calcium (Ca<sup>2&#x2b;</sup>) levels. The obtained results demonstrated that T-cadinol affected neither the parasite plasma membrane nor the electric potential of the membrane. Nevertheless, this compound induced a mitochondrial impairment, resulting in a hyperpolarization of the membrane potential, with decreased levels of reactive oxygen species. No alterations in Ca<sup>2&#x2b;</sup> levels were observed, suggesting that T-cadinol may affect the single mitochondria of the parasite. This is the first report about the occurrence of T-cadinol in <italic>C. sylvestris</italic>, and our data suggest this sesquiterpene as an interesting hit compound for future optimizations in drug discovery studies for Chagas disease.</p>
</abstract>
<kwd-group>
<kwd>
<italic>Trypanosoma cruzi</italic>
</kwd>
<kwd>
<italic>Casearia sylvestris</italic>
</kwd>
<kwd>Salicaceae</kwd>
<kwd>T-cadinol</kwd>
<kwd>Chagas disease</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Background</title>
<p>Neglected tropical diseases (NTDs) are a group of parasitic diseases that affect more than one billion people worldwide, corresponding to 12% of the global health burden, and generating a massive social, as well as, economic impact (<xref ref-type="bibr" rid="B47">Who, 2017</xref>). Among the NTDs, Chagas disease (CD) is considered endemic, with approximately 14 thousand deaths per year (<xref ref-type="bibr" rid="B9">De Rycker et&#x20;al., 2018</xref>). The etiologic agent of CD is the kinetoplastid <italic>Trypanosoma cruzi</italic>, which could be detected as extracellular (trypomastigote) or intracellular (amastigote) forms. In humans, the intracellular amastigotes can persist for decades, leading to a severe cardiomegaly and damage to the digestive tract (megacolon) (<xref ref-type="bibr" rid="B19">Kratz, 2019</xref>). Moreover, current therapies for CD were introduced in the 1970s and comprise benznidazole and nifurtimox (<xref ref-type="bibr" rid="B40">Ribeiro et&#x20;al., 2020</xref>), with several side effects and reduced efficacy, especially in the chronic phase of this disease. Therefore, there is an urgent need of new alternative treatments for CD, including compounds, which could be obtained from natural sources such as plants, animals, and microorganisms (<xref ref-type="bibr" rid="B34">Newman and Cragg, 2020</xref>).</p>
<p>
<italic>Casearia</italic>, belonging to Salicaceae, is popularly known in Brazil as &#x201c;gua&#xe7;atonga,&#x201d; a term originated from the Tupi&#x2013;Guarani language, indicating an ancient use of this species in Brazilian indigenous communities (<xref ref-type="bibr" rid="B11">Ferreira et&#x20;al., 2011;</xref> <xref ref-type="bibr" rid="B14">Grandi, 2014</xref>; <xref ref-type="bibr" rid="B2">Ameni et&#x20;al., 2015</xref>). In this genus, there are more than 50 different species, but just few of these were evaluated from a pharmacological or chemical point of view (<xref ref-type="bibr" rid="B49">Xia et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B26">Marquete Mederios, 2020</xref>). The ethnopharmacological uses of <italic>C. sylvestris</italic> include antiseptic and cicatrizing in skin diseases, anti-inflammatory, anti-ophidic, anti-pyretic, and anti-ulcer effects; this potential is frequently associated to the presence of oxidized clerodane diterpenes known as casearins and caseavestrins (<xref ref-type="bibr" rid="B15">Itokawa et&#x20;al., 1990</xref>; <xref ref-type="bibr" rid="B11">Ferreira et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B12">Ferreira et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B49">Xia et&#x20;al., 2015</xref>). The antiparasitic potential of diterpenoids from <italic>C. sylvestris</italic> was previously reported, including the <italic>in&#x20;vitro</italic> action of the leaves extract (<xref ref-type="bibr" rid="B29">Mesquita et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B3">Antinarelli et&#x20;al., 2015</xref>) and casearins A, B, G, and J against <italic>Leishmania</italic> spp<italic>.</italic> and <italic>T. cruzi</italic> (<xref ref-type="bibr" rid="B8">Bou et&#x20;al., 2014</xref>). Casearin X, one of the main compounds found in <italic>C. sylvestris</italic>, also displayed <italic>in&#x20;vitro</italic> cytotoxic activity against several cell lines including antitumor potential in preclinical assays (<xref ref-type="bibr" rid="B49">Xia et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B13">Ferreira et&#x20;al., 2016</xref>).</p>
<p>In the present work, the fractionation of the hexane phase obtained from the MeOH extract from the leaves of <italic>C. sylvestris</italic> afforded the sesquiterpene T-cadinol, which was chemically characterized by nuclear magnetic resonance (NMR), mass spectrometry (MS) analysis, and polarimetric data. The antitrypanosomal activity of this compound was evaluated in the extracellular trypomastigotes and intracellular amastigotes of <italic>Trypanosoma cruzi</italic>. A mechanism of action study was also performed, using spectrofluorimetric and flow cytometry assays to evaluate the plasma membrane permeability, the electric potential of the plasma membrane, the mitochondrial membrane potential, reactive oxygen species (ROS) levels, and the intracellular calcium levels. In trypanosomatids, these organelles have been extensively studied in drug discovery as essential sites for targeting new drug candidates.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>General Experimental Section</title>
<p>
<sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded at 300 and 75&#xa0;MHz, respectively, on a Bruker Ultrashield 300 Advance III spectrometer (Bruker&#x2013;Biospin, Germany). DMSO (Aldrich) was used as the solvent and as the internal standard. ESI&#x2013;HRMS were obtained in a Bruker Daltonics microTOF-QII (ESI&#x2013;QTOF positive mode). Silica gel (Merck, 230&#x2013;400 mesh) and Sephadex LH-20 were used for the chromatographic column (CC) separation, while silica gel (SiO<sub>2</sub>) 60 PF<sub>254</sub> (Merck) was used for analytical thin layer chromatography.</p>
</sec>
<sec id="s2-2">
<title>Plant Material</title>
<p>The leaves of <italic>C. sylvestris</italic> were collected from a single tree in the Atlantic Forest district of S&#xe3;o Paulo City, SP, Brazil (coordinates 23&#x20;53&#x2032;08.86&#x2033;S, 46&#x20;40&#x2032;10.45&#x2033;O), in October 2012. Botanical identification was made by Dr. Roseli Buzanelli Torres, and the leaves were deposited into the IAC Herbarium with the voucher number IAC 55272. The research project was registered in the Sistema de Patrim&#xf4;nio Gen&#xe9;tico e Conhecimento Tradicional Associado (Sisgen) platform, with the registration number A90708B.</p>
</sec>
<sec id="s2-3">
<title>Extraction, Fractionation, and Purification of T-Cadinol</title>
<p>Dried and powdered leaves of <italic>C. sylvestris</italic> (290&#xa0;g) were extracted using MeOH (5 &#xd7; 1&#xa0;L) at room temperature. After filtration and concentration under reduced pressure, the crude MeOH extract was resuspended in MeOH:H<sub>2</sub>O (9:1, v/v) and partitioned with <italic>n</italic>-hexane, CH<sub>2</sub>Cl<sub>2</sub>, EtOAc, and <italic>n</italic>-BuOH. These extracts were stored under refrigeration in an inert atmosphere and absence of light until its fractionation. After that, the <italic>n</italic>-hexane phase was evaluated and exhibited anti&#x2013;<italic>T. cruzi</italic> activity (100% of trypomastigotes death at 300&#xa0;&#x3bc;g/ml), so it was selected for fractionation procedures.</p>
<p>The hexane phase (6.4&#xa0;g) was submitted by CC using SiO<sub>2</sub> eluted with <italic>n</italic>-hexane with increased amounts of EtOAc to afford 10 fractions (I to X). Part of fraction V (1,076&#xa0;mg) was subjected to CC over Sephadex LH-20 eluted with MeOH, to give four fractions (V-1 to V-4). Fraction V-2 (204.7&#xa0;mg) was submitted to CC over SiO<sub>2</sub> eluted with increased amounts of acetone in CH<sub>2</sub>Cl<sub>2</sub> to give pure compound <bold>1</bold> (35&#xa0;mg).</p>
</sec>
<sec id="s2-4">
<title>Parasites and Mammalian Cell Maintenance</title>
<p>
<italic>T. cruzi</italic> trypomastigotes (Y strain) were cultivated in the Rhesus monkey kidney cells (LLC-MK2, ATCC CCL 7) and were maintained in the RPMI-1640 medium (Sigma-Aldrich) supplemented with 2% FBS at 37&#xb0;C in a 5% CO<sub>2</sub> humidified incubator. Murine fibroblasts cells (NCTC clone L929, ATCC) and LLC-MK2 were maintained in the RPMI-1640 supplemented with 10% FBS at the same conditions described above. Macrophages were collected from the peritoneal cavity of BALB/c mice with RPMI-1640 supplemented with 10% FBS and were maintained in a 5% CO<sub>2</sub> humidified incubator at 37&#xb0;C.</p>
</sec>
<sec id="s2-5">
<title>Evaluation of the Antitrypanosomal Activity</title>
<p>The solvent DMSO was used to dissolve the compounds. To avoid toxic effects in the parasites and mammalian cells, it was added at 0.5% (v/v) in the microplate wells and used as the internal control. The 50% inhibitory concentration (IC<sub>50</sub>) was determined against <italic>T. cruzi</italic> trypomastigote (<italic>i</italic>) and amastigote (<italic>ii</italic>) forms, as follows:<list list-type="simple">
<list-item>
<p>
<italic>i</italic>) <italic>Trypomastigotes</italic>: Trypomastigotes (1 &#xd7; 10<sup>6</sup>/well) were seeded in 96-well plates and incubated with compound <bold>1</bold> up to 150&#xa0;&#x3bc;M for 24&#xa0;h at 37&#xb0;C in a 5% CO<sub>2</sub> incubator. The parasite viability was determined using the resazurin (Alamar Blue<sup>&#xae;</sup>) colorimetric method. Benznidazole was used as the standard drug, and the untreated cells were used as the negative control (<xref ref-type="bibr" rid="B4">Barbosa et&#x20;al., 2020</xref>). The mortality of the parasites induced by fractions (bioguided fractionation) was performed using the incubation of trypomastigotes at a fixed concentration of 300&#xa0;&#xb5;g/ml for 24&#xa0;h at 37&#xb0;C in a 5% CO<sub>2</sub> incubator. The parasite viability was analyzed by light microscopy (&#xd7; 400 magnification) by the motility and morphology of the parasites compared to the untreated&#x20;group.</p>
</list-item>
<list-item>
<p>
<italic>ii</italic>) <italic>Amastigotes</italic>: Peritoneal macrophages (1 &#xd7; 10<sup>5</sup>&#xa0;cells/well) were seeded in 16-well slide chambers (NUNC, Merck) and infected with trypomastigotes at a ratio of 10:1 (parasite/macrophage). After 2&#xa0;h of incubation at 37&#xb0;C in a 5% CO<sub>2</sub> incubator, the cells were treated with compound <bold>1</bold>&#xa0;at different concentrations for 48&#xa0;h. Benznidazole was used as the standard drug and the untreated cells as a negative control. Slides were stained with Giemsa, analyzed in a digital light microscope (EVOS M5000 Thermo Fisher, United&#x20;States), and the IC<sub>50</sub> values were calculated by the infection index (<xref ref-type="bibr" rid="B22">Londero et&#x20;al., 2018</xref>).</p>
</list-item>
</list>
</p>
</sec>
<sec id="s2-6">
<title>Cytotoxicity Against Mammalian Cells</title>
<p>NCTC cells (6 &#xd7; 10<sup>4</sup>&#xa0;cells/well), murine fibroblasts (ATCC), were seeded in 96-well plates and incubated with serial dilutions (base 2-fold) of compound <bold>1</bold> (200&#x2013;1.6&#xa0;&#x3bc;M) for 48&#xa0;h in a 5% CO<sub>2</sub> incubator at 37&#xb0;C. The 50% cytotoxic concentration (CC<sub>50</sub>) was determined by the MTT colorimetric method (<xref ref-type="bibr" rid="B44">Tada et&#x20;al., 1986</xref>). The selectivity index (SI) value was calculated using the ratio: CC<sub>50</sub> against NCTC cells/IC<sub>50</sub> against <italic>T. cruzi</italic> amastigotes.</p>
</sec>
<sec id="s2-7">
<title>Evaluation of the Plasma Membrane Permeability</title>
<p>Trypomastigotes (2 &#xd7; 10<sup>6</sup>&#xa0;cells/well) were seeded in the 96-well black polystyrene microplates and incubated with 1&#xa0;&#x3bc;M of SYTOX Green (Molecular Probes) in HANKS&#x2019; balanced salt solution (Sigma-Aldrich) supplemented with 10&#xa0;mM <sc>d</sc>-Glucose (Sigma-Aldrich, HBSS &#x2b; Glu) in the dark at 24&#xb0;C. After 15&#x20;min, compound <bold>1</bold> was added at IC<sub>50</sub> concentration (18.2&#xa0;&#x3bc;M) and the fluorescence was monitored for 4&#xa0;h using a fluorimetric microplate reader (FilterMax F5-Molecular Devices) with excitation and emission wavelengths of 485 and 535&#xa0;nm, respectively. Maximum permeabilization was obtained with 0.5% Triton X-100 (positive control), and untreated parasites were considered as the negative control (<xref ref-type="bibr" rid="B28">Mesquita et&#x20;al., 2014</xref>).</p>
</sec>
<sec id="s2-8">
<title>Assessment of Plasma Membrane Electric Potential (&#x394;&#x3a8;p)</title>
<p>Trypomastigotes (2 &#xd7; 10<sup>6</sup>&#xa0;cells/well) were treated with compound <bold>1</bold> (18.2&#xa0;&#x3bc;M) in HBSS &#x2b; Glu for 4&#xa0;h at 37&#xb0;C in a 5% CO<sub>2</sub> incubator. Subsequently, 0.2&#xa0;&#xb5;M of DiSBAC<sub>2</sub> 3) (Molecular Probes) were added and the samples were incubated at 37&#xb0;C for 5&#xa0;min. The fluorescence was measured using the Attune NxT flow cytometer (Thermo Fisher Scientific) with excitation and emission wavelengths of 488 and 574&#xa0;nm, respectively. The parasites were treated with gramicidin D (0.5&#xa0;&#xb5;g/ml) (Sigma-Aldrich) (positive control) and the untreated parasites served as a negative control (<xref ref-type="bibr" rid="B30">Morais et&#x20;al., 2019</xref>).</p>
</sec>
<sec id="s2-9">
<title>Determination of Mitochondrial Membrane Electric Potential (&#x394;&#x3a8;m)</title>
<p>Trypomastigotes (2 &#xd7; 10<sup>6</sup>&#xa0;cells/well) were incubated with compound <bold>1</bold> (18.2&#xa0;&#x3bc;M) in HBSS &#x2b; Glu for 4&#xa0;h at 37&#xb0;C in a 5% CO<sub>2</sub> incubator. The parasites were stained with JC-1 dye (Thermo Fisher) at 10&#xa0;&#x3bc;M in the dark for 20&#xa0;min, and fluorescence levels were measured using the Attune NxT flow cytometer (Thermo Fisher Scientific) with an excitation filter wavelength of 488&#xa0;nm, and emission wavelengths of 530&#xa0;nm (BL-1) and 574&#xa0;nm (BL-2). The &#x394;&#x3a8;<sub>m</sub> was determined by the ratio BL-2/BL-1. CCCP (100&#xa0;&#x3bc;M) (Sigma-Aldrich) treated parasites were used as a positive control and the untreated parasites as a negative control (<xref ref-type="bibr" rid="B23">Luque-Ortega and Rivas, 2010</xref>).</p>
</sec>
<sec id="s2-10">
<title>Reactive Oxygen Species Analysis</title>
<p>Trypomastigotes (2 &#xd7; 10<sup>6</sup>&#xa0;cells/well) were treated with compound <bold>1</bold> (18.2&#xa0;&#x3bc;M) for 4&#xa0;h in HBSS &#x2b; Glu at 37&#xb0;C in a 5% CO<sub>2</sub> incubator. H<sub>2</sub>DCFDA (molecular probe) was added (5&#xa0;&#x3bc;M), and the parasites were incubated for 15&#xa0;min. Then, the fluorescence intensity was measured using a fluorimetric microplate reader (FilterMax F5&#x20;Multi-Mode, Molecular Devices) with an excitation wavelength of 485&#xa0;nm and an emission wavelength of 535&#xa0;nm. Sodium azide (10&#xa0;mM) was used as a positive control and the untreated parasites were used as a negative control (<xref ref-type="bibr" rid="B18">Keil et&#x20;al., 2011</xref>).</p>
</sec>
<sec id="s2-11">
<title>Assessment of Intracellular Calcium (Ca<sup>2&#x2b;</sup>) Levels</title>
<p>Trypomastigotes (2 &#xd7; 10<sup>6</sup>&#xa0;cells/well) were pretreated with 5&#xa0;&#x3bc;M of Fluo-4 AM (Molecular Probes) in PBS 1x, for 60&#xa0;min at 37&#xb0;C in the dark. Then, the parasites were washed and treated with compound <bold>1</bold> (18.2&#xa0;&#x3bc;M). Fluorescence measurements were performed for 4&#xa0;h using a fluorimetric microplate reader (FilterMax F5&#x20;Multi-Mode, Molecular Devices) with the excitation and emission wavelengths of 485 and 535&#xa0;nm, respectively. Maximum calcium levels were obtained using 0.5% Triton X-100 and the untreated parasites were used as a negative control (<xref ref-type="bibr" rid="B39">Rea et&#x20;al., 2013</xref>).</p>
</sec>
<sec id="s2-12">
<title>Statistical Analysis</title>
<p>The 50% inhibitory concentrations and 50% cytotoxic concentration values were calculated using sigmoidal dose&#x2013;response curves using GraphPad Prism 6.0 software. Unless stated, the reported data correspond to the mean&#x20;&#xb1; standard deviation of at least two independent experiments performed with duplicate samples. The one-way ANOVA of variance with Tukey&#x2019;s multiple comparison test was used for the significance test (<italic>p</italic> value).</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>Results and Discussion</title>
<p>To evaluate the anti&#x2013;<italic>T. cruzi</italic> potential of the hexane phase from the MeOH extract of <italic>C. sylvestris</italic>, this material was tested <italic>in&#x20;vitro</italic> against trypomastigote forms. By using bioguided fractionation to isolate only bioactive compounds, the parasites were incubated at 300&#xa0;&#x3bc;g/ml, and the morphology and motility observed under light microscopy. This approach afforded a bioactive fraction composed by the sesquiterpene (-)-T-cadinol <bold>1</bold>) whose structure was identified based on the spectrometric analyses. The ESI&#x2013;HRMS of compound <bold>1</bold> showed the [M &#x2b; H]<sup>&#x2b;</sup> peak at <italic>m/z</italic> 223.2071, indicating a molecular formula C<sub>15</sub>H<sub>26</sub>O (calcd for C<sub>15</sub>H<sub>27</sub>O<sup>&#x2b;</sup> 223.2062).The <sup>1</sup>H NMR spectrum of compound <bold>1</bold> displayed hydrogen signals belonging to the methyl groups as a pair of doublets at &#x3b4;<sub>H</sub> 0.74 and 0.87 (<italic>J</italic>&#x20;&#x3d; 6.9&#xa0;Hz, 3H each), which were assigned to the methyl component of an isopropyl group (H-12 and H-13), besides, singlets at &#x3b4;<sub>H</sub> 1.09 (3H) and 1.60 (3H) are assigned to CH<sub>3</sub>-15 and CH<sub>3</sub>-14, respectively. Also, the spectrum showed a broad singlet at the &#x3b4;<sub>H</sub> 5.48 (1H) characteristic of an olefinic H-5, and four multiplets at &#x3b4;<sub>H</sub> 1.23, 1.96, 1.30, and 1.80 assigned to methynic hydrogen H-1, H-6, H-7, and H-11 respectively. Additional peaks, ranging from &#x3b4;<sub>H</sub> 1.54 to &#x3b4; 1.96, correspond to the remaining hydrogen H-2, H-3, H-8, and H-9.The <sup>13</sup>C and DEPT NMR spectra showed 15 carbon signals, corresponding to four methyl, four methylene, four methine, and three quaternary carbons, in order to confirming the occurrence of a sesquiterpene derivative. The cadinane skeleton was proposed due to the presence of signals attributed to sp<sup>2</sup> carbons at &#x3b4;<sub>C</sub> 133.8 (C-4) and 123.4 (C-5), to the carbinolic carbon at &#x3b4;<sub>C</sub> 69.0 (C-10), and the methyl groups at &#x3b4;<sub>C</sub> 21.1 (C-12), 15.7 (C-13), 24.1 (C-14), and 29.0 (C-15). The comparison of the obtained data with those reported in the literature of (&#x2b;)-T-cadinol (<xref ref-type="bibr" rid="B20">Labbe et&#x20;al., 1993</xref>) allowed the identification of compound <bold>1</bold> as the enantiomer (-)-T-cadinol (<xref ref-type="fig" rid="F1">Figure&#x20;1</xref>), since the isolated compound exhibited the opposite value of specific optical rotation ( [&#x3b1;] <inline-formula id="inf1">
<mml:math id="m1">
<mml:mrow>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mtable>
<mml:mtr>
<mml:mtd>
<mml:mrow>
<mml:mn>20</mml:mn>
</mml:mrow>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mi>D</mml:mi>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:mrow>
</mml:math>
</inline-formula> -28; <italic>c</italic> 0,42 in CHCl<sub>3</sub>) of that reported to the (&#x2b;)-isomer.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>
<bold>-</bold> Structure of (-)-&#x3a4;-cadinol (<bold>1</bold>).</p>
</caption>
<graphic xlink:href="fphar-12-734127-g001.tif"/>
</fig>
<p>
<statement>
<p>
<italic>Casearia</italic> genus is known for the production of diterpenoids, especially those with the rearranged clerodane skeleton, known as casearins. Sesquiterpenes occur in a minority, and were well described in the essential oils from the leaves of <italic>C. sylvestris</italic> with biological activities against tumor cell lines (<xref ref-type="bibr" rid="B7">Bou et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B36">Pereira et&#x20;al., 2017a</xref>), antileishmanial (<xref ref-type="bibr" rid="B31">Moreira et&#x20;al., 2019</xref>), antifungal (<xref ref-type="bibr" rid="B37">Pereira et&#x20;al., 2017b</xref>), gastric anti-ulcer, and anti-inflammatory (<xref ref-type="bibr" rid="B10">Esteves et&#x20;al., 2005</xref>). Moreover, only two main compounds found in the essential oil from <italic>C. sylvestris</italic> were explored about their biological activity. BOU <italic>et&#x20;al.</italic> (2013) isolated <italic>&#x3b1;</italic>-zingiberene from the essential oil of <italic>C. sylvestris,</italic> and this compound as well as some semi-synthetic derivatives showed cytotoxic potential against tumor cell lines. In addition, MOREIRA <italic>et&#x20;al.</italic> (2019) reported the identification of <italic>E</italic>-caryophyllene in the essential oil of <italic>C. sylvestris,</italic> and both showed activity and selectivity to <italic>Leishmania amazonensis</italic> amastigotes (<xref ref-type="bibr" rid="B31">Moreira et&#x20;al., 2019</xref>). The essential oil of <italic>C. lasyophilla</italic> leaves afforded <italic>&#x3b1;</italic>-cadinol (<xref ref-type="bibr" rid="B41">Salvador et&#x20;al., 2011</xref>), an isomer of T-cadinol, isolated in the present work, from the bioactive <italic>n</italic>-hexane phase from the MeOH extract from the leaves of <italic>C. sylvestris</italic>. The antiparasitic activity of T-cadinol is discussed below, and corroborates the biological potential for the plant that is a rich source of bioactive prototypes, especially terpenoids (sequi and diterpenoids).</p>
</statement>
</p>
<sec id="s3-1">
<title>Antitrypanosomal Activity</title>
<p>Compound <bold>1</bold> was evaluated <italic>in&#x20;vitro</italic> against <italic>T. cruzi.</italic> and displayed activity against amastigotes and trypomastigotes forms of parasite with IC<sub>50</sub> values of 15.8 and 18.2&#xa0;&#xb5;M, respectively (<xref ref-type="table" rid="T1">Table&#x20;1</xref>). Light microscopy analysis (&#xd7;400 magnification) revealed that compound <bold>1</bold> eliminated the intracellular amastigotes with selectivity, killing &#x3e;95% of the parasites at 30&#xa0;&#xb5;M (<xref ref-type="fig" rid="F2">Figure&#x20;2</xref>), preserving the morphology of the host cells. At 15&#xa0;&#x3bc;M, it was possible to observe 50% reduction of the amastigotes, when compared to the untreated macrophages (<italic>T.cruzi</italic>-infected) (<xref ref-type="fig" rid="F2">Figure&#x20;2</xref>). The intracellular amastigotes are the clinically relevant forms of the parasite, and are mainly present in the chronic phase of the disease (<xref ref-type="bibr" rid="B1">Alonso-Padilla and Rodr&#xed;guez, 2014</xref>); while the trypomastigotes is also of therapeutic importance, once this form is widely found at the acute phase of the human disease. If not completely eliminated during the drug treatment, trypomastigotes can lead to the reactivation of the parasitemia and disease transmission (<xref ref-type="bibr" rid="B17">Katsuno et&#x20;al., 2015</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>
<bold>-</bold> Anti&#x2013;<italic>T. cruzi</italic> activity and mammalian cytotoxicity of compound <bold>1</bold> (T-cadinol).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left">Compound</th>
<th colspan="2" align="center">IC<sub>50</sub> (&#xb5;M&#x20;&#xb1; SD)</th>
<th rowspan="2" align="center">CC<sub>50</sub> (&#xb5;M&#x20;&#xb1; SD)</th>
<th rowspan="2" align="center">SI</th>
</tr>
<tr>
<th align="center">Trypomastigote</th>
<th align="center">Amastigote</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">1</td>
<td align="char" char="plusmn">18.2&#x20;&#xb1; 7.7</td>
<td align="char" char="plusmn">15.8&#x20;&#xb1; 10.3</td>
<td align="center">&#x3e;200</td>
<td align="char" char=".">&#x3e;12</td>
</tr>
<tr>
<td align="left">Benznidazole</td>
<td align="char" char="plusmn">17.7&#x20;&#xb1; 1.9</td>
<td align="char" char="plusmn">5.0&#x20;&#xb1; 1.5</td>
<td align="center">190.6&#x20;&#xb1; 13.4</td>
<td align="char" char=".">38.1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>IC<sub>50</sub>, 50% inhibitory concentration; CC<sub>50</sub>, 50% cytotoxic concentration; SI, selectivity index (CC<sub>50</sub> mammalian cells/IC<sub>50</sub> amastigotes); SD, standard deviation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Light microscopy micrographs (&#xd7; 400 magnification) of <italic>T. cruzi</italic>&#x2013;infected macrophages treated with compound <bold>1</bold>&#xa0;at 30 and 15&#xa0;&#xb5;M. The untreated macrophages (<italic>T.cruzi</italic>&#x2013;infected) were used as control. The images were acquired using the digital microscope EVOS M500 (Thermo-United&#x20;States).</p>
</caption>
<graphic xlink:href="fphar-12-734127-g002.tif"/>
</fig>
<p>Regarding the mammalian cytotoxicity, no toxic profile of the cells was detected after treatment with compound <bold>1</bold> to the highest tested concentration. Using the ratio between the cytotoxicity and activity against amastigotes, the selectivity index (SI) of this sesquiterpene was &#x3e;12. Benznidazole showed an IC<sub>50</sub> value against the intracellular amastigotes of 5.0&#xa0;&#xb5;M, and a mammalian cytotoxicity (CC<sub>50</sub>) of 190.6&#xa0;&#xb5;M, resulting in a selective index of&#x20;38.1<italic>.</italic>
</p>
<p>Essential oils containing the T-cadinol (<bold>1</bold>) from different plants such as <italic>Cymbopogon nardus</italic> (<xref ref-type="bibr" rid="B35">Norhayati et&#x20;al., 2013</xref>), <italic>Kadsura longipedunculata</italic> (<xref ref-type="bibr" rid="B33">Mulyaningsih et&#x20;al., 2010</xref>), and <italic>Humulus lupulus</italic> (<xref ref-type="bibr" rid="B16">Jeliazkova et&#x20;al., 2018</xref>) have demonstrated the activity against the etiologic agent of the African trypanosomiasis (<italic>Trypanosoma brucei</italic>). Considering the promising activity of T-cadinol against both forms of <italic>T. cruzi</italic> and the lack of mammalian cytotoxicity, we suggest that this compound could be used as a hit candidate for future optimization studies on drug discovery against Chagas disease.</p>
</sec>
<sec id="s3-2">
<title>Mechanism of Action Studies</title>
<p>Considering the potent and selective activity of T-cadinol (<bold>1</bold>) against <italic>T. cruzi</italic>, we investigated the lethal action using the extracellular trypomastigotes. During drug discovery studies, the study of the target organelles of a hit candidate can provide significant information for the synthesis of new derivatives (<xref ref-type="bibr" rid="B45">Tiwari et&#x20;al., 2018</xref>). The following assays were carried out in trypomastigotes at the 50% inhibitory concentration.</p>
</sec>
<sec id="s3-3">
<title>Plasma Membrane Permeability</title>
<p>The plasma membrane is an essential regulator of ions and nutrient transport, as well as pH homeostasis, acting as a barrier between the extra and intracellular environments. In the present study, the plasma membrane permeability of <italic>T. cruzi</italic> parasites was analyzed spectrofluorimetrically, using the probe SYTOX Green. Our results showed that compound <bold>1</bold> induced no permeabilization of the membrane when compared to the untreated parasites (<xref ref-type="fig" rid="F3">Figure&#x20;3</xref>), similar to the eudesmane sesquiterpene costic acid, isolated from <italic>Nectandra barbellata</italic> (Lauraceae) (<xref ref-type="bibr" rid="B21">Londero et&#x20;al., 2020</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>
<bold>&#x2013;</bold> Evaluation of plasma membrane permeabilization in <italic>T. cruzi</italic> trypomastigotes treated with compound 1 (<italic>T-cadinol</italic> &#x2212;18.2&#xa0;&#x3bc;M) for 4&#xa0;h. Sytox<sup>&#xae;</sup> Green dye fluorescence was monitored spectrofluorimetrically (excitation 485&#xa0;nm and emission 535&#xa0;nm) every 20&#xa0;min. Untreated trypomastigotes and those treated with 0.5% TX-100 were used as negative and positive controls, respectively. Fluorescence is reported as the percentage relative to time 0&#xa0;min (0%) and TX-100 240&#xa0;min (100%). &#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.0001.</p>
</caption>
<graphic xlink:href="fphar-12-734127-g003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Plasma Membrane Electric Potential (&#x394;&#x3a8;p)</title>
<p>The membrane potential and the differences in ion concentrations between the intracellular and the extracellular millie determine the flow of ions in channels. Alterations in the potential can lead to an ionic imbalance and the formation of transmembrane pores, affecting the acquisition of crucial nutrients for proliferation and cellular activities (<xref ref-type="bibr" rid="B32">Morth et&#x20;al., 2011</xref>). In the present work, using the fluorophore DiSBAC<sub>2</sub> in flow cytometry, it was possible to verify that the compound <bold>1</bold> caused no interference in the membrane when compared to untreated parasites (<xref ref-type="fig" rid="F4">Figure&#x20;4</xref>). It suggests that T-cadinol enters the plasma membrane of the parasite without affecting the gradient of cations (Na<sup>&#x2b;</sup>, Ca<sup>2&#x2b;</sup>, and K<sup>&#x2b;</sup>) and anions Cl<sup>&#x2212;</sup>,that forces ions to passively move in one direction. Considering the lethal activity of T-cadinol (<bold>1</bold>) in the trypomastigotes, our initial approaches suggest other mechanisms of action of the compound than the parasite plasma membrane damage.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>
<bold>&#x2013;</bold> Evaluation of plasma membrane electric potential (&#x394;&#x3a8;p) in <italic>T. cruzi</italic> trypomastigotes treated with compound <bold>1</bold> (T-cadinol &#x2212;18.2&#xa0;&#x3bc;M) for 4&#xa0;h. DISBAC2(3) dye fluorescence was measured by flow cytometry (excitation 488&#xa0;nm and emission 574&#xa0;nm). Untreated trypomastigotes were used to achieve minimal depolarization and treated with gramicidin D (0.5&#xa0;&#xb5;g/ml) to achieve the maximum. Fluorescence was normalized with respect to gramicidin D (100%). &#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.0001.</p>
</caption>
<graphic xlink:href="fphar-12-734127-g004.tif"/>
</fig>
<p>Protozoan parasites present membrane structures with considerable differences in lipids and proteins relative to the mammalian cells. These are essential for parasite specific processes, such as host cell invasion, nutrient acquisition or protection against the host immune system (<xref ref-type="bibr" rid="B46">Vial et&#x20;al., 2003</xref>). Despite the attractive approach to target <italic>T. cruzi</italic> membrane with natural products, compound <bold>1</bold> showed no interference in this site and we proceeded to investigate other organelles.</p>
</sec>
<sec id="s3-5">
<title>Mitochondrial Membrane Electric Potential (&#x394;&#x3a8;m)</title>
<p>From energy production to oxidative stress control, the mitochondria is responsible for innumerable metabolic processes. This organelle is involved in the growth and differentiation, being crucial to the cell survival. Additionally, unlike mammalian cells, trypanosomatids exhibit a unique mitochondria, which extends throughout the parasite length (<xref ref-type="bibr" rid="B27">Menna&#x2013;Barreto and Medeiros, 2014</xref>). Due to these factors, the search for compounds that affect this essential organelle could be an interesting strategy for the search of new anti&#x2013;<italic>T. cruzi</italic> therapies.</p>
<p>To analyze the mitochondrial membrane of <italic>T. cruzi</italic> trypomastigotes, the fluorescence of JC-1 dye was used in the flow cytometer. This fluorophore indicates changes in the mitochondrial membrane potential according to the formation of J-aggregates (BL-2 fluorescence) and monomers (BL-1 fluorescence). Our data showed an intense hyperpolarization of the mitochondrial membrane, leading to a significant enhance in the BL-2/BL-1 ratio when compared to the untreated parasites (<xref ref-type="fig" rid="F5">Figure&#x20;5</xref>). Previous reports of two other natural sesquiterpenes, costic acid isolated from <italic>Nectandra barbellata</italic> (<xref ref-type="bibr" rid="B21">Londero et&#x20;al., 2020</xref>) and deoxymikanolide isolated from the species of <italic>Mikania</italic> (<xref ref-type="bibr" rid="B38">Puente et&#x20;al., 2019</xref>), demonstrated an imbalance of the <italic>T. cruzi</italic> mitochondria, but leading to a depolarization of this organelle. The mitochondria in trypanosomatid are unique and vital organelles, serving as target for several drugs and compounds. The current findings established the essential role of the mitochondria in protozoan parasites and their peculiarities as compared to the mammalian counterpart, which is being considered an attractive candidate for drug discovery (<xref ref-type="bibr" rid="B43">Sundar and Singh, 2018</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>
<bold>-</bold> Evaluation of mitochondrial membrane potential (&#x2206;&#x3c8;<sub>m</sub>) in <italic>T. cruzi</italic> trypomastigotes treated with compound <bold>1</bold> (T-cadinol &#x2212;18.2&#xa0;&#x3bc;M) for 4&#xa0;h. JC-1 dye fluorescence was monitored by flow cytometry (excitation 488&#xa0;nm and emission 530/574&#xa0;nm). Untreated trypomastigotes and those treated with CCCP (100&#xa0;&#x3bc;M) were used to achieve minimal and maximal depolarization, respectively. Fluorescence is reported as the ratio between the emission channels BL2/BL1. &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.0021 and <italic>p</italic>&#x3c;&#x2a;0.05.</p>
</caption>
<graphic xlink:href="fphar-12-734127-g005.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>Reactive Oxygen Species</title>
<p>Mitochondria are the principal resource of reactive oxygen species such as superoxide anions, hydrogen peroxide, and hydroxyl radicals. Under normal conditions, the respiratory chain generates around 3&#x2013;5% of ROS over the total oxygen consumed, and these species are used as signalization in the cell proliferation and growth. Therefore, derangements in the mitochondria can affect the production of these species, caused from interference in different biosynthetic pathways to lethal oxidative stress <xref ref-type="bibr" rid="B24">(Machado-Silva et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B25">Maldonado et&#x20;al., 2020</xref>). Considering the effect of compound <bold>1</bold> in the mitochondria, the ROS levels in <italic>T. cruzi</italic> using the fluorescent probe H<sub>2</sub>DCFDA was also investigated. The results demonstrated that compound <bold>1</bold> induced a slight decrease in the ROS levels, characterizing a reduced fluorescence when compared to the untreated parasites (<xref ref-type="fig" rid="F6">Figure&#x20;6</xref>). This reduction can be attributed to the mitochondrial membrane hyperpolarization, since the breakdown of the respiratory chain can cause a disorder of the proton motive force and consequently, the alteration of the ROS production.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>
<bold>-</bold> Evaluation of reactive oxygen species (ROS) production in <italic>T. cruzi</italic> trypomastigotes treated with compound <bold>1</bold> (T-cadinol &#x2212;18.2&#xa0;&#x3bc;M) for 4&#xa0;h H<sub>2</sub>DCFDA dye fluorescence was measured spectrofluorimetrically (excitation 485&#xa0;nm and emission 535&#xa0;nm). Untreated trypomastigotes were used as a negative control, and those treated with sodium azide (10&#xa0;mM) as a positive control. Fluorescence was normalized with respect to untreated trypomastigotes (100%). &#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.0001 and <italic>p</italic>&#x3c;&#x2a;0.05.</p>
</caption>
<graphic xlink:href="fphar-12-734127-g006.tif"/>
</fig>
<p>The function of the mitochondria is the production of metabolic energy in the form of ATP. Most of the oxygen consumed by the mitochondrial electron transport chain is reduced to water, and a small proportion is converted to ROS (1&#x2013;2%) (<xref ref-type="bibr" rid="B48">Wiley et&#x20;al., 2014</xref>). The reduction of ROS caused by the compound 1 suggests a damage to the bioenergetic activity of <italic>T. cruzi</italic> mitochondria, as corroborated by the studies of the <italic>&#x394;&#x3a8;</italic>
<sub>
<italic>m.</italic>
</sub>
</p>
</sec>
<sec id="s3-7">
<title>Intracellular Calcium (Ca<sup>2&#x2b;</sup>)</title>
<p>Intracellular calcium is an important cell signaling component and plays a key role in trypanosomatids infectivity, mobility, and differentiation. These ions are concentrated mostly in the endoplasmic reticulum, mitochondria, and acidocalcisomes. Basically, failure in any Ca<sup>2&#x2b;</sup> regulation pathway or storage disarranges homeostasis and can be extremely harmful to the parasites. Additionally, variations in the mitochondrial calcium induce high conductance channel formation across the membrane, disturbing the electrical potential (<xref ref-type="bibr" rid="B5">Benaim et&#x20;al., 2020a</xref>; <xref ref-type="bibr" rid="B42">Scarpelli et&#x20;al., 2021</xref>).</p>
<p>In the present work, Ca<sup>2&#x2b;</sup> levels were spectrofluorimetrically evaluated employing the Fluo-4 AM dye. The obtained results showed that compound <bold>1</bold> caused no interference in the intracellular calcium levels of <italic>T. cruzi</italic> when compared to the untreated parasites (<xref ref-type="fig" rid="F7">Figure&#x20;7</xref>). Based on these findings, it is possible to assume that the mitochondrial impairment caused by <italic>T-cadinol</italic> (<bold>1</bold>) has no direct relationship to a Ca<sup>2&#x2b;</sup> extrusion effect. Further studies should be performed to clarify if T-cadinol (<bold>1</bold>) has a direct effect in the mitochondria or can also affect other metabolic pathways at early time of incubation. Despite Ca<sup>2&#x2b;</sup> imbalance has been considered an attractive strategy against <italic>Trypanosoma cruzi</italic> parasites, both the single mitochondria and the acidocalcisomes have been considered important targets for drug discovery studies, as they play essential roles in the bioenergetics of these protozoan parasites (<xref ref-type="bibr" rid="B6">Benaim et&#x20;al., 2020b</xref>).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>
<bold>-</bold> Evaluation of intracellular Ca<sup>2&#x2b;</sup> levels in <italic>T. cruzi</italic> trypomastigotes treated with compound <bold>1</bold> (T-cadinol &#x2212;18.2&#xa0;&#x3bc;M) for 4&#xa0;h. Fluo-4 AM dye fluorescence was monitored spectrofluorimetrically (excitation 485&#xa0;nm and emission 535&#xa0;nm). Untreated trypomastigotes and those treated with 0.5% TX-100 were used as negative and positive controls, respectively. Fluorescence is reported as the percentage relative to time 0&#xa0;min (100%). &#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.0001.</p>
</caption>
<graphic xlink:href="fphar-12-734127-g007.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>Conclusion</title>
<p>In the present work, <italic>C. sylvestris</italic> was found to be an important source of anti&#x2013;<italic>T. cruzi</italic> natural products with T-cadinol (<bold>1</bold>) isolated for the first time from this plant. We also demonstrated unprecedentedly the selective and potent activity of compound <bold>1</bold> against amastigote and trypomastigote forms of <italic>T. cruzi</italic>, with no cytotoxicity to mammalian cells. The mechanism of the action analysis of compound <bold>1</bold> showed that the mitochondria are affected, but future studies are needed to confirm this organelle as a candidate target. Overall, T-cadinol (<bold>1</bold>) is a promising scaffold for optimization studies in drug discovery to the treatment of Chagas disease.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/Supplementary Material; further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by the Animal Care and Use Committee from Instituto Adolfo Lutz&#x2013;Secretary of Health of Sao Paulo State (Project number CTC 21H/2015, CEUA 04/2016) in agreement with the Guide for the Care and Use of Laboratory Animals from the National Academy of Sciences.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>Project design: AT, PS; experimental work, data collection, and evaluation: AS, MA, FH, AT, and PS; literature search and manuscript preparation: AT, MA, AT, and PS; funding acquisition: AT and PS; investigation: AT, MA, AT, and PS; spectral analysis and interpretations: JL and PS; project administration: AT, PS; writing&#x2013;original draft: AS, AT, and PS; writing&#x2013;review and editing: JL, AT, and&#x20;PS.</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>The authors thank FAPESP (grants 2021/02789-7 to JL, 2016/24985-4 and 2018/10279-6) for financial support for the development of this work. We also thank CAPES fellowships to ALS (Finance Code 001, Brazil) and CNPq for the scientific research awards of PS, AT, and JL. This study was registered in the Sistema Nacional de Gest&#x00E3;o do Patrim&#x00F4;nio Gen&#x00E9;tico e do Conhecimento Tradicional Associado (SisGen &#x23; A90708B). This publication is part of the activities of the Research Network Natural Products against Neglected Diseases (ResNet NPND).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alonso-Padilla</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rodr&#xed;guez</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>High Throughput Screening for Anti-trypanosoma Cruzi Drug Discovery</article-title>. <source>Plos Negl. Trop. Dis.</source> <volume>8</volume>, <fpage>e3259</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0003259</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ameni</surname>
<given-names>A. Z.</given-names>
</name>
<name>
<surname>Latorre</surname>
<given-names>O. A.</given-names>
</name>
<name>
<surname>Torres</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>G&#xf3;rniak</surname>
<given-names>S. L.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Toxicity Study about a Medicinal Plant <italic>Casearia Sylvestris</italic>: A Contribution to the Brazilian Unified Health System (SUS)</article-title>. <source>J.&#x20;Ethnopharmacol</source> <volume>175</volume>, <fpage>9</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2015.08.027</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antinarelli</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>N. C.</given-names>
</name>
<name>
<surname>Scio</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Coimbra</surname>
<given-names>E. S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Antileishmanial Activity of Some Brazilian Plants, with Particular Reference to <italic>Casearia Sylvestris</italic>
</article-title>. <source>Acad. Bras Cienc</source> <volume>87</volume>, <fpage>733</fpage>&#x2013;<lpage>742</lpage>. <pub-id pub-id-type="doi">10.1590/0001-3765201520140288</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbosa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>R. L. C. G.</given-names>
</name>
<name>
<surname>Costa-Silva</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Tempone</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Antar</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Lago</surname>
<given-names>J.&#x20;H. G.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Interaction of Dicentrinone, an Antitrypanosomal Aporphine Alkaloid Isolated from <italic>Ocotea Puberula</italic> (Lauraceae), in Cell Membrane Models at the Air-Water Interface</article-title>. <source>Bioorg. Chem.</source> <volume>101</volume>, <fpage>103978</fpage>. <pub-id pub-id-type="doi">10.1016/j.bioorg.2020.103978</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benaim</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Paniz-Mondolfi</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Sordillo</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Martinez-Sotillo</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2020a</year>). <article-title>Disruption of Intracellular Calcium Homeostasis as a Therapeutic Target against <italic>Trypanosoma Cruzi</italic>
</article-title>. <source>Front Cel Infect Microbiol</source> <volume>10</volume>, <fpage>46</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2020.00046</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benaim</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Paniz-Mondolfi</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Sordillo</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Martinez-Sotillo</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2020b</year>). <article-title>Disruption of Intracellular Calcium Homeostasis as a Therapeutic Target against <italic>Trypanosoma Cruzi</italic>
</article-title>. <source>Front. Cel Infect Microbiol</source> <volume>10</volume>, <fpage>46</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2020.00046</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bou</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Lago</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Figueiredo</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Matsuo</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Guadagnin</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Soares</surname>
<given-names>M. G.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Chemical Composition and Cytotoxicity Evaluation of Essential Oil from Leaves of Casearia Sylvestris, its Main Compound &#x3b1;-zingiberene and Derivatives</article-title>. <source>Molecules</source> <volume>18</volume>, <fpage>9477</fpage>&#x2013;<lpage>9487</lpage>. <pub-id pub-id-type="doi">10.3390/molecules18089477</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bou</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Tempone</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>&#xc9;. G.</given-names>
</name>
<name>
<surname>Lago</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Sartorelli</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Antiparasitic Activity and Effect of Casearins Isolated from <italic>Casearia Sylvestris</italic> on <italic>Leishmania</italic> and <italic>Trypanosoma Cruzi</italic> Plasma Membrane</article-title>. <source>Phytomedicine</source> <volume>21</volume>, <fpage>676</fpage>&#x2013;<lpage>681</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2014.01.004</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Rycker</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Baraga&#xf1;a</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Duce</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>I. H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Challenges and Recent Progress in Drug Discovery for Tropical Diseases</article-title>. <source>Nature</source> <volume>559</volume>, <fpage>498</fpage>&#x2013;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-018-0327-4</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esteves</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Souza</surname>
<given-names>I. R.</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cardoso</surname>
<given-names>L. G.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Sertie</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Gastric Antiulcer and Anti-inflammatory Activities of the Essential Oil from <italic>Casearia Sylvestris</italic> Sw</article-title>. <source>J.&#x20;Ethnopharmacol</source> <volume>101</volume>, <fpage>191</fpage>&#x2013;<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2005.04.020</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Costa-Lotufo</surname>
<given-names>L. V.</given-names>
</name>
<name>
<surname>Moraes</surname>
<given-names>M. O.</given-names>
</name>
<name>
<surname>Barros</surname>
<given-names>F. W.</given-names>
</name>
<name>
<surname>Martins</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Cavalheiro</surname>
<given-names>A. J.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Folk Uses and Pharmacological Properties of <italic>Casearia Sylvestris</italic>: a Medicinal Review</article-title>. <source>Acad. Bras Cienc</source> <volume>83</volume>, <fpage>1373</fpage>&#x2013;<lpage>1384</lpage>. <pub-id pub-id-type="doi">10.1590/s0001-37652011005000040</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Milit&#xe3;o</surname>
<given-names>G. C.</given-names>
</name>
<name>
<surname>Lima</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>N. D.</given-names>
</name>
<name>
<surname>Machado</surname>
<given-names>Kda. C.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>A. G.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Morphological and Biochemical Alterations Activated by Antitumor Clerodane Diterpenes</article-title>. <source>Chem. Biol. Interact</source> <volume>222</volume>, <fpage>112</fpage>&#x2013;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2014.10.015</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname>
<given-names>P. M. P.</given-names>
</name>
<name>
<surname>Bezerra</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>J.&#x20;D. N.</given-names>
</name>
<name>
<surname>da Costa</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>J.&#x20;R. O.</given-names>
</name>
<name>
<surname>Alencar</surname>
<given-names>N. M. N.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Preclinical Anticancer Effectiveness of a Fraction from <italic>Casearia Sylvestris</italic> and its Component Casearin X: <italic>In Vivo</italic> and <italic>Ex Vivo</italic> Methods and Microscopy Examinations</article-title>. <source>J.&#x20;Ethnopharmacol</source> <volume>186</volume>, <fpage>270</fpage>&#x2013;<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2016.04.011</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grandi</surname>
<given-names>T. S. M.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Tratado das plantas medicinais: mineiras, nativas e cultivadas</article-title>. <source>Adequatio Est&#xfa;dio</source>, <fpage>978</fpage>&#x2013;<lpage>985</lpage>. <comment>58322-00-0</comment>. </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Itokawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Totsuka</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Morita</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Takeya</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Iitaka</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>SchenkeL</surname>
<given-names>E. P.</given-names>
</name>
<etal/>
</person-group> (<year>1990</year>). <article-title>New Antitumor Principles, Casearins A-F, for <italic>Casearia Sylvestris</italic> Sw. (Flacourtiaceae)</article-title>. <source>Chem. Pharm. Bull. (Tokyo)</source> <volume>38</volume>, <fpage>3384</fpage>&#x2013;<lpage>3388</lpage>. <pub-id pub-id-type="doi">10.1248/cpb.38.3384</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeliazkova</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>D Zheljazkov</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ka&#x10d;&#xe1;niova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Astatkie</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>L Tekwani</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Sequential Elution of Essential Oil Constituents during Steam Distillation of Hops (<italic>Humulus Lupulus</italic> L.) and Influence on Oil Yield and Antimicrobial Activity</article-title>. <source>J.&#x20;Oleo Sci.</source> <volume>67</volume>, <fpage>871</fpage>&#x2013;<lpage>883</lpage>. <pub-id pub-id-type="doi">10.5650/jos.ess17216</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katsuno</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Burrows</surname>
<given-names>J.&#x20;N.</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hooft van Huijsduijnen</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kaneko</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kita</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Hit and lead Criteria in Drug Discovery for Infectious Diseases of the Developing World</article-title>. <source>Nat. Rev. Drug Discov.</source> <volume>14</volume>, <fpage>751</fpage>&#x2013;<lpage>758</lpage>. <pub-id pub-id-type="doi">10.1038/nrd4683</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keil</surname>
<given-names>V. C.</given-names>
</name>
<name>
<surname>Funke</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zeug</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schild</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>M&#xfc;ller</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Ratiometric High-Resolution Imaging of JC-1 Fluorescence Reveals the Subcellular Heterogeneity of Astrocytic Mitochondria</article-title>. <source>Pflugers Arch.</source> <volume>462</volume>, <fpage>693</fpage>&#x2013;<lpage>708</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-011-1012-8</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kratz</surname>
<given-names>J.&#x20;M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Drug Discovery for Chagas Disease: A Viewpoint</article-title>. <source>Acta Trop.</source> <volume>198</volume>, <fpage>105107</fpage>. <pub-id pub-id-type="doi">10.1016/j.actatropica.2019.105107</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Labbe</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Castillo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Connolly</surname>
<given-names>J.&#x20;D.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Mono and Sesquiterpenoids from <italic>Satureja Gilliesii</italic>
</article-title>. <source>Phytochemistry</source> <volume>34</volume>, <fpage>441</fpage>&#x2013;<lpage>444</lpage>. <pub-id pub-id-type="doi">10.1016/0031-9422(93)80026-o</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Londero</surname>
<given-names>V. S.</given-names>
</name>
<name>
<surname>Costa-Silva</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Tempone</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Namiyama</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Thevenard</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Antar</surname>
<given-names>G. M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Anti-<italic>Trypanosoma Cruzi</italic> Activity of Costic Acid Isolated from <italic>Nectandra Barbellata</italic> (Lauraceae) Is Associated with Alterations in Plasma Membrane Electric and Mitochondrial Membrane Potentials</article-title>. <source>Bioorg. Chem.</source> <volume>95</volume>, <fpage>103510</fpage>. <pub-id pub-id-type="doi">10.1016/j.bioorg.2019.103510</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Londero</surname>
<given-names>V. S.</given-names>
</name>
<name>
<surname>da Costa-Silva</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Gomes</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Mesquita</surname>
<given-names>J.&#x20;T.</given-names>
</name>
<name>
<surname>Tempone</surname>
<given-names>A. G.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Acetylenic Fatty Acids from <italic>Porcelia Macrocarpa</italic> (Annonaceae) against Trypomastigotes of <italic>Trypanosoma Cruzi</italic>: Effect of Octadec-9-Ynoic Acid in Plasma Membrane Electric Potential</article-title>. <source>Bioorg. Chem.</source> <volume>78</volume>, <fpage>307</fpage>&#x2013;<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1016/j.bioorg.2018.03.025</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luque-Ortega</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<name>
<surname>Rivas</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Characterization of the Leishmanicidal Activity of Antimicrobial Peptides</article-title>. <source>Methods Mol. Biol.</source> <volume>618</volume>, <fpage>393</fpage>&#x2013;<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-60761-594-1_25</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Machado-Silva</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cerqueira</surname>
<given-names>P. G.</given-names>
</name>
<name>
<surname>Grazielle-Silva</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gadelha</surname>
<given-names>F. R.</given-names>
</name>
<name>
<surname>Peloso</surname>
<given-names>Ede. F.</given-names>
</name>
<name>
<surname>Teixeira</surname>
<given-names>S. M.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>How <italic>Trypanosoma Cruzi</italic> Deals with Oxidative Stress: Antioxidant Defence and DNA Repair Pathways</article-title>. <source>Mutat. Res. Rev. Mutat. Res.</source> <volume>767</volume>, <fpage>8</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.mrrev.2015.12.003</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maldonado</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rojas</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Morales</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Miralles</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Solari</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Dual and Opposite Roles of Reactive Oxygen Species (ROS) in Chagas Disease: Beneficial on the Pathogen and Harmful on the Host</article-title>. <source>Oxid Med. Cel Longev</source> <volume>2020</volume>, <fpage>8867701</fpage>. <pub-id pub-id-type="doi">10.1155/2020/8867701</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Marquete</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Medeiros</surname>
<given-names>E. V. S. S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Salicaceae in Flora Do Brasil 2020 Em Constru&#xe7;&#xe3;o</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://floradobrasil.jbrj.gov.br/reflora/floradobrasil/FB14361%3e.%20Acesso%20em">http://floradobrasil.jbrj.gov.br/reflora/floradobrasil/FB14361&#x3e;. Acesso em</ext-link> (Dispon&#xed;vel em September 14, 2021)</comment>. </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menna-Barreto</surname>
<given-names>R. F.</given-names>
</name>
<name>
<surname>de Castro</surname>
<given-names>S. L.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>The Double-Edged Sword in Pathogenic Trypanosomatids: the Pivotal Role of Mitochondria in Oxidative Stress and Bioenergetics</article-title>. <source>Biomed. Res. Int.</source> <volume>2014</volume>, <fpage>614014</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1155/2014/614014</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mesquita</surname>
<given-names>J.&#x20;T.</given-names>
</name>
<name>
<surname>da Costa-Silva</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Borborema</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Tempone</surname>
<given-names>A. G.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Activity of Imidazole Compounds on <italic>Leishmania</italic> (L.) <italic>Infantum Chagasi</italic>: Reactive Oxygen Species Induced by Econazole</article-title>. <source>Mol. Cel Biochem</source> <volume>389</volume>, <fpage>293</fpage>&#x2013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1007/s11010-013-1954-6</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mesquita</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Desrivot</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bories</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fournet</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Paula</surname>
<given-names>J.&#x20;E.</given-names>
</name>
<name>
<surname>Grellier</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Antileishmanial and Trypanocidal Activity of Brazilian Cerrado Plants</article-title>. <source>Mem. Inst. Oswaldo Cruz</source> <volume>100</volume>, <fpage>783</fpage>&#x2013;<lpage>787</lpage>. <pub-id pub-id-type="doi">10.1590/s0074-02762005000700019</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morais</surname>
<given-names>T. R.</given-names>
</name>
<name>
<surname>Costa-Silva</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Novais</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Torrecilhas</surname>
<given-names>A. C. T.</given-names>
</name>
<name>
<surname>Tempone</surname>
<given-names>A. G.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Antitrypanosomal Activity and Effect in Plasma Membrane Permeability of (-)-bornyl P-Coumarate Isolated from Piper Cernuum (Piperaceae)</article-title>. <source>Bioorg. Chem.</source> <volume>89</volume>, <fpage>103001</fpage>. <pub-id pub-id-type="doi">10.1016/j.bioorg.2019.103001</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreira</surname>
<given-names>R. R. D.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>A. G. d.</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Perego</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Crevelin</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Crotti</surname>
<given-names>A. E. M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Antileishmanial Activity of Melampodium Divaricatum and Casearia Sylvestris Essential Oils on Leishmania Amazonensis</article-title>. <source>Revista do Instituto de Medicina Trop. de S&#xe3;o Paulo</source> <volume>61</volume>, <fpage>e33</fpage>. <pub-id pub-id-type="doi">10.1590/s1678-9946201961033</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morth</surname>
<given-names>J.&#x20;P.</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>B. P.</given-names>
</name>
<name>
<surname>Buch-Pedersen</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>J.&#x20;P.</given-names>
</name>
<name>
<surname>Vilsen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Palmgren</surname>
<given-names>M. G.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>A Structural Overview of the Plasma Membrane Na&#x2b;,K&#x2b;-ATPase and H&#x2b;-ATPase Ion Pumps</article-title>. <source>Nat. Rev. Mol. Cel Biol</source> <volume>12</volume>, <fpage>60</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3031</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mulyaningsih</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Youns</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>El-Readi</surname>
<given-names>M. Z.</given-names>
</name>
<name>
<surname>Ashour</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Nibret</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sporer</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Biological Activity of the Essential Oil of <italic>Kadsura Longipedunculata</italic> (Schisandraceae) and its Major Components</article-title>. <source>J.&#x20;Pharm. Pharmacol.</source> <volume>62</volume>, <fpage>1037</fpage>&#x2013;<lpage>1044</lpage>. <pub-id pub-id-type="doi">10.1111/j.2042-7158.2010.01119.x</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newman</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Cragg</surname>
<given-names>G. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019</article-title>. <source>J.&#x20;Nat. Prod.</source> <volume>83</volume>, <fpage>770</fpage>&#x2013;<lpage>803</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.9b01285</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muhd Haffiz</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Norhayati</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Getha</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nor Azah</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Mohd Ilham</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lili Sahira</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Chemical Composition and <italic>In Vitro</italic> Antitrypanosomal Activity of Fractions of Essential Oil from <italic>Cymbopogon Nardus</italic> L</article-title>. <source>Trop. Biomed.</source> <volume>30</volume> (<issue>1</issue>), <fpage>9</fpage>&#x2013;<lpage>14</lpage>. </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pereira</surname>
<given-names>F. G.</given-names>
</name>
<name>
<surname>Marquete</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Domingos</surname>
<given-names>L. T.</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>M. E. N.</given-names>
</name>
<name>
<surname>Ferreira-Pereira</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mansur</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2017a</year>). <article-title>Antifungal Activities of the Essential Oil and its Fractions Rich in Sesquiterpenes from Leaves of <italic>Casearia Sylvestris</italic> Sw</article-title>. <source>Acad. Bras Cienc</source> <volume>89</volume>, <fpage>2817</fpage>&#x2013;<lpage>2824</lpage>. <pub-id pub-id-type="doi">10.1590/0001-3765201720170339</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pereira</surname>
<given-names>F. G.</given-names>
</name>
<name>
<surname>Marquete</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Oliveira-Cruz</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Quintanilha-Falcao</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mansur</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Moreira</surname>
<given-names>D. D.</given-names>
</name>
</person-group> (<year>2017b</year>). <article-title>Cytotoxic Effects of the Essential Oil from Leaves of <italic>Casearia Sylvestris</italic> Sw. (Salicaceae) and its Nanoemulsion on A549 Tumor Cell Line</article-title>. <source>Bol Latinoam. Caribe Plantas Med. Arom&#xe1;t.</source> <volume>16</volume>, <fpage>506</fpage>&#x2013;<lpage>512</lpage>. </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puente</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Laurella</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Spina</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Lozano</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>V. S.</given-names>
</name>
<name>
<surname>Sosa</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Primary Targets of the Sesquiterpene Lactone Deoxymikanolide on <italic>Trypanosoma Cruzi</italic>
</article-title>. <source>Phytomedicine</source> <volume>56</volume>, <fpage>27</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2018.10.015</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rea</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tempone</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>E. G.</given-names>
</name>
<name>
<surname>Mesquita</surname>
<given-names>J.&#x20;T.</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>L. G.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Soulamarin Isolated from Calophyllum Brasiliense (Clusiaceae) Induces Plasma Membrane Permeabilization of Trypanosoma Cruzi and Mytochondrial Dysfunction</article-title>. <source>Plos Negl. Trop. Dis.</source> <volume>7</volume>, <fpage>e2556</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0002556</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ribeiro</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Dias</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Paiva</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hagstr&#xf6;m-Bex</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Nitz</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Pratesi</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Current Trends in the Pharmacological Management of Chagas Disease</article-title>. <source>Int. J.&#x20;Parasitol. Drugs Drug Resist.</source> <volume>12</volume>, <fpage>7</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpddr.2019.11.004</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salvador</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>J.&#x20;E. d.</given-names>
</name>
<name>
<surname>Wisniewski-Jrm</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kassuya</surname>
<given-names>C. A. L.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>&#xc9;. P.</given-names>
</name>
<name>
<surname>Riva</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Chemical Composition and Cytotoxic Activity of the Essential Oil from the Leaves of <italic>Casearia Lasiophylla</italic>
</article-title>. <source>Rev. Bras. Farmacogn.</source> <volume>21</volume>, <fpage>864</fpage>&#x2013;<lpage>868</lpage>. <pub-id pub-id-type="doi">10.1590/s0102-695x2011005000073</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scarpelli</surname>
<given-names>P. H.</given-names>
</name>
<name>
<surname>Pecenin</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>C. R. S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Intracellular Ca2&#x2b; Signaling in Protozoan Parasites: An Overview with a Focus on Mitochondria</article-title>. <source>Ijms</source> <volume>22</volume>, <fpage>469</fpage>. <pub-id pub-id-type="doi">10.3390/ijms22010469</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sundar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Emerging Therapeutic Targets for Treatment of Leishmaniasis</article-title>. <source>Expert Opin. Ther. Targets</source> <volume>22</volume>, <fpage>467</fpage>&#x2013;<lpage>486</lpage>. <pub-id pub-id-type="doi">10.1080/14728222.2018.1472241</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tada</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shiho</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Kuroshima</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Koyama</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tsukamoto</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>1986</year>). <article-title>An Improved Colorimetric Assay for Interleukin 2</article-title>. <source>J.&#x20;Immunol. Methods</source> <volume>93</volume>, <fpage>157</fpage>&#x2013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1016/0022-1759(86)90183-3</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tiwari</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gedda</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Tiwari</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>R. K.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Limitations of Current Therapeutic Options, Possible Drug Targets and Scope of Natural Products in Control of Leishmaniasis</article-title>. <source>Mini Rev. Med. Chem.</source> <volume>18</volume>, <fpage>26</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.2174/1389557517666170425105129</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vial</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Eldin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tielens</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>van Hellemond</surname>
<given-names>J.&#x20;J.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Phospholipids in Parasitic Protozoa</article-title>. <source>Mol. Biochem. Parasitol.</source> <volume>126</volume>, <fpage>143</fpage>&#x2013;<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1016/s0166-6851(02)00281-5</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="book">
<collab>WHO</collab> (<year>2017</year>). <source>Integrating Neglected Tropical Diseases into Global Health and Development: Fourth WHO Report on Neglected Tropical Diseases</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>. </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiley</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ashok</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Martin-Ruiz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Talbot</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Collerton</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kingston</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Reactive Oxygen Species Production and Mitochondrial Dysfunction in White Blood Cells Are Not Valid Biomarkers of Ageing in the Very Old</article-title>. <source>PLOS ONE</source> <volume>9</volume>, <fpage>e91005</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0091005</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The Genus <italic>Casearia</italic>: a Phytochemical and Pharmacological Overview</article-title>. <source>Phytochem. Rev.</source> <volume>14</volume>, <fpage>99</fpage>&#x2013;<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1007/s11101-014-9336-6</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>